Epigral Ltd (EPIGRAL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003523, "name": "Epigral", "stock_name": "Epigral", "full_name": "Epigral Ltd", "name_url": "stocks-analysis/epigral", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,071.85", "chg": -23.85, "chgp": "-2.18%", "dir": -1, "prev_price": "1,095.70", "mcapval": "4,700.00 Cr", "mcap": "Small Cap", "scripcode": 543332, "symbol": "EPIGRAL", "ind_name": "Specialty Chemicals", "ind_code": 11, "sector_id": 74, "indexname": "India SENSEX", "isin": "INE071N01016", "curr_date": "Sep 24, 03:30 PM", "curr_time": "07:04 AM", "last_traded_at": "Sep 24, 03:30 PM IST", "bse_nse_vol": "34.84 k", "exc_status": "Active", "traded_date": "Sep 24, 2026", "traded_date_str": "2026 09 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Epigral Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-4200721", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_mojoScore_4200721.png", "date": "2026-09-22 09:00:55", "description": "Epigral Ltd, a specialty chemicals company, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 21 September 2026. This change reflects a nuanced improvement in technical indicators alongside a more attractive valuation, despite ongoing challenges in financial performance and long-term growth. The company’s Mojo Score now stands at 58.0, signalling a cautious but more optimistic stance among analysts." }, { "title": "Epigral Ltd Technical Momentum Shifts Signal Mild Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-amid-mixed-indicators-4200452", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_technicaldot_4200452.png", "date": "2026-09-22 08:07:39", "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, which collectively suggest cautious optimism for investors amid mixed signals." }, { "title": "Epigral Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4199811", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_mojoScore_4199811.png", "date": "2026-09-21 10:10:04", "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Epigral Ltd Declines 2.02% Amid Mixed Technical Signals and Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-declines-202-amid-mixed-technical-signals-and-sector-challenges-4198121", "imagepath": "", "date": "2026-09-19 12:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Stock declines 3.39% amid bearish technical momentum</p>\n <p><strong>17 Sep:</strong> Golden Cross forms, signalling potential bullish breakout</p>\n <p><strong>18 Sep:</strong> Technical momentum shifts to sideways with mixed signals</p>\n <p><strong>Week Close:</strong> Rs.1,106.00, down 2.02% vs Sensex -0.41%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,128.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-mixed-market-signals-4196801", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_technicaldot_4196801.png", "date": "2026-09-18 08:04:40", "description": "Epigral Ltd, a small-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, transitioning from a bearish trend to a sideways pattern. Despite a modest day gain of 1.44%, the stock’s technical indicators present a complex picture, with some signals suggesting mild bullishness while others remain bearish, reflecting uncertainty in near-term price direction." }, { "title": "Golden Cross Forms in Epigral Ltd — Mixed Technical Signals Cloud the Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4196592", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_goldencross_4196592.png", "date": "2026-09-17 18:00:35", "description": "The 50-day moving average has crossed above the 200-day moving average for Epigral Ltd, signalling a golden cross on 17 Sep 2026. Yet, the broader technical indicators and recent price action present a nuanced picture that tempers the enthusiasm often associated with this crossover." }, { "title": "Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-bearish-sentiment-4194297", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_technicaldot_4194297.png", "date": "2026-09-16 08:09:29", "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex." }, { "title": "Epigral Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4189268", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_mojoScore_4189268.png", "date": "2026-09-10 10:10:26", "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 September 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector", "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-specialty-chemicals-sector-4188470", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EpigralLtd_valuationdot_4188470.png", "date": "2026-09-10 08:01:18", "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite recent headwinds reflected in its share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within a challenging market environment." } ], "total": 655, "sid": "1003523", "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "16-Sep-2026", "details": "Epigral Limited (the Company) hereby informs that the officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "31-Aug-2026", "details": "Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "18-Aug-2026", "details": "Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26", "dt": "2026-06-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Sep: Stock declines 3.39% amid bearish technical momentum

17 Sep: Golden Cross forms, signalling potential bullish breakout

18 Sep: Technical momentum shifts to sideways with mixed signals

Week Close: Rs.1,106.00, down 2.02% vs Sensex -0.41%

Week Open

Rs.1,128.80

Week Close

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-18 08:04:40

Epigral Ltd, a small-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, transitioning from a bearish trend to a sideways pattern. Despite a modest day gain of 1.44%, the stock’s technical indicators present a complex picture, with some signals suggesting mild bullishness while others remain bearish, reflecting uncertainty in near-term price direction.

Read full news article

Golden Cross Forms in Epigral Ltd — Mixed Technical Signals Cloud the Outlook

2026-09-17 18:00:35

The 50-day moving average has crossed above the 200-day moving average for Epigral Ltd, signalling a golden cross on 17 Sep 2026. Yet, the broader technical indicators and recent price action present a nuanced picture that tempers the enthusiasm often associated with this crossover.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment

2026-09-16 08:09:29

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex.

Read full news article

Epigral Ltd is Rated Sell by MarketsMOJO

2026-09-10 10:10:26

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector

2026-09-10 08:01:18

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite recent headwinds reflected in its share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within a challenging market environment.

Read full news article